Published by Iain Gilbert on 14th July 2026
(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that it has signed an exclusive licensing deal with Dizal Pharmaceutical for Zegfrovy, its non‑small cell lung cancer treatment, securing global rights to develop and commercialise the drug.
URL: http://www.digitallook.com/dl/news/story/36069376/...